Vice President Yemi Osinbajo says the federal government intends to examine every possible option in the development and distribution of a vaccine against the COVID-19 disease.
Osinbajo disclosed this during a virtual meeting with representatives of the BNT162 COVID-19 vaccine candidate on the progress of the vaccine development around the world, including Africa.
The Vice President said the health and safety of Nigerian citizens remains top priority of the Buhari administration.
The meeting was attended by the Health Minister, Dr Osagie Ehanire and the Executive Director of the National Primary Health Care Development Agency, Dr. Faisal Shuaib with representatives of Pfizer and Biotech, the international pharmaceutical firms promoting the BNT162 vaccine candidate.
Also Read: VP Osinbajo identifies synergy as key to solving border issues
According to Osinbajo, the interaction between the FG and the promoters of the vaccine candidate “is an important conversation and it is important for us that we are prioritized-as the largest country in Africa-in the distribution of the best COVID-19 vaccine when it’s eventually ready.
During the meeting, the Vice President asked several questions about the COVID-19 vaccine candidate including how quickly can Nigeria get the vaccine once it’s safely ready.
Responding, the Pfizer Country Manager and Representative in Africa, who spoke for the promoters, Mr. Subair Olayinka disclosed that “Nigeria will be a priority,” for the vaccine supply to Africa.
Although the vaccine trials are not going on in Nigeria currently he said the trails are ongoing in parts of the African continent and it would be entering the third phase, having concluded the first two phases successfully.
Also speaking the Minister of Health Osagie Ehanire said the federal government would consider quality, appropriate volume and how well and quick a vaccine can be delivered to Nigeria in deciding which manufacturer to make the supply.
(Editor : Nkoli Omhoudu)
